Purchase Order 75F40122P00299
Award Date 7/27/22
Potential Completion Date 1/31/23
Potential Value $58K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St Charles, MO, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $723,710.98 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for non-clinical and laboratory support services and has a period of performance through September 2028. The contract is not associated with a specific set-aside program. Eurofins Discovery Services North America, LLC holds several multi-million dollar...
- This is a $7,997.76 firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit organization, for in-vitro safety and toxicity drug testing services. The contract has an ultimate completion date of September 30, 2024 and was awarded on April 22, 2024. It is not a set-aside contract. Eurofins Discovery Services North America, LLC is a contract research organization that specializes in...
- This is a $38,639.60 firm-fixed-price delivery order contract awarded to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization, by the Food and Drug Administration (FDA). The contract is to provide in vitro screening services on a panel of biological targets to predict the safety of food chemicals. This contract is part of a larger $20 million single-award indefinite delivery vehicle (IDV) the FDA awarded to Eurofins Panlabs for research and development services and...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order valued at approximately $1 million to Eurofins Discoverx Products, LLC for binding studies. The contract is to be performed in Fremont, California over a one year period ending August 2024. Eurofins Discoverx will provide binding assay services in support of NIH's efforts to facilitate the movement of scientific observations...
- This is a $132,771.58 firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for receptor profile screening services in support of NIDA's drug abuse research programs. It has a period of performance from June 25, 2025 to June 24, 2026. The contract is not set aside for any small...
- This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
- This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
- The National Institute on Drug Abuse issued a $136,499.26 delivery order to Eurofins Discovery Services North America, LLC on September 1, 2026, for receptor profile screening under a Total Small Business set-aside. Performance runs September 1, 2026 through August 31, 2027, at the awardee's facility in St. Charles, MO. The order is priced firm fixed price. Receptor profile screening supports the Institute's drug abuse research initiatives and involves advanced binding studies and related...
- The National Institute of Allergy and Infectious Diseases issued a $62,300.01 delivery order to Eurofins Discovery Services North America, LLC on July 14, 2021, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ for screening of rodent pharmacokinetics in support of lead optimization. Place of performance is St. Charles, MO. The order was firm fixed price with an ultimate completion date of July 14, 2022. The award obligated fiscal year 2021 funds in...
- This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...